ArticleCurrent cardiology reviews2025
Adaptive Immune System in Hypertension: Implicating the Role of T Cells.
Article in Current cardiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEmerging scientific evidence supports the essential role of inflammation as one of the factors in the development of hypertension. The immune system plays a crucial role in the body's defense mechanism and in promoting tissue regeneration after injury. When the immune system overreacts to an insult or injury, collateral damage can result in hypertension.
methodsA comprehensive literature search was conducted to collect and analyse articles related to the role of the adaptive immune system, particularly T cells and their cytokines. It was conducted in scientific databases, including PubMed, ScienceDirect, and Google Scholar, to identify relevant articles published between 2000 and 2024, ensuring an up-to-date collection of scientific evidence. The following keywords and Medical Subject Headings (MeSH terms) were used: hypertension, immune system, T cells, cytokines, IL-10, TNF-α, IL-17, IFN-γ, and renal inflammation. These keywords helped capture both basic mechanisms and clinical findings relevant to the immune-mediated mechanism of hypertension. Only peer-reviewed original research articles and review articles in English were included. Preference was given to articles focused on cytokine synthesis, expression, release, and their signalling pathways, as well as hypertension- related target organ damage, especially in the kidney and blood vessels. All the articles were thoroughly analysed to extract information on the involvement of T cell-derived cytokines in promoting immune activation, monocyte infiltration, sodium retention, vascular dysfunction, and endothelial impairment, which all contribute to the pathogenesis of hypertension.
resultsAccording to the reference articles, TNF-α, IL-17, and IFN-γ stimulate vascular inflammation, sodium retention, endothelial dysfunction, and renal inflammation. DISCUSSION: The roles of T cells and the associated cytokines in regulating blood pressure are thoroughly discussed. It can activate oxidative stress and result in renal sodium imbalance, as well as interaction with the RAAS system and oxidative stress pathway, culminating in the exacerbation of blood pressure.
conclusionIt is concluded that cytokines play a significant role in the development of hypertension, and targeting them might be a plausible pharmacological intervention for managing blood pressure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.